STERILE COMPOUNDING: 503B OUTSOURCING FACILITIES, HOSPITAL PHARMACIST INTRO

With the challenges of increasing costs to hospital pharmacies to upgrade and validate facilities, qualify sterile compounding personnel, and manage daily work load, a 503b outsourcing facility can be used to fill the gap between traditional pharmacy compounding and the ability to produce larger scale batch size of commonly used medication for health system organizations.

Learning Objectives
Upon completion of this activity, the participant should be able to:
Compare the key differences between 503a vs 503b
Define cGMP.
Explain the pharmacist’s role in 503a vs 503b.
Identify who has regulatory oversight of 503a vs 503b.
Determine how to choose a 503b facility.